Patterns in the occurrence and development of tumors

Chinese Medical Journal

Volumn 124, Issue 7, 2011, Pages 1097-1104

  Lin, Zhi xiong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Feedback regulation; Micro ecosystem; Neoplasms; Tumorigenesis

Indexed keywords

CYTOKINE;

ANGIOGENESIS; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CYTOKINE RELEASE; ENDOTHELIUM CELL; GLIOMA; HOMEOSTASIS; HUMAN; METASTASIS; MICROENVIRONMENT; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TUMOR DERIVED MICROVASCULAR ENDOTHELIAL CELL; TUMOR DIFFERENTIATION;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 79954459183     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.07.027     Document Type: Review

References (81)

1. Barrett JC. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 1993; 100: 9-20.
2. Marx J. Debate surges over the origins of genomic defects in cancer. Science 2002; 297: 544-546.
3. Czernin J, Weber WA, Herschman HR. Molecular imaging in the development of cancer therapeutics. Annu Rev Med 2006; 57: 99-118.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, cancer stem cells. Nature 2001; 414: 105-111.
5. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004; 103: 2332-2336.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
7. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
8. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-835.
9. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65: 9328-9337.
10. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.
11. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007; 120: 1598-1602.
12. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cell 2006; 24: 506-513.
13. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 583-598.
14. Bomken S, Fiser K, Heidenreich O, Vormoor J. Understanding the cancer stem cell. Br J Cancer 2010; 103: 439-445.
15. Kim Y, Lin Q, Glazer PM, Yun Z. Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med 2009; 9: 425-434.
16. Hill RP, Marie-Egyptienne DT, Hedley DW. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009; 19: 106-111.
17. Rejniak KA, McCawley LJ. Current trends in mathematical modeling of tumor-microenvironment interactions: a survey of tools and applications. Exp Biol Med (Maywood) 2010; 235: 411-423.
18. Hu M, Polyak K. Molecular characterization of the tumour microenvironment in breast cancer. Eur J Cancer 2008; 44: 2760-2765.
19. Baird L, Terskikh A. The tumor microenvironment. Adv Exp Med Biol 2010; 671: 67-73.
20. Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature 2001; 411: 375-379.
21. Foidart JM, Polette M, Birembaut P, Noel A. Breast cancer invasion: the key role of normal cells of host tissues. Bull Acad Natl Med 1994; 178: 533-544.
22. Mareel M, Oliveira MJ, Madani I. Cancer invasion and metastasis: interacting ecosystems. Virchows Arch 2009; 454: 599-622.
23. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000; 6: 324-329.
24. Cheshier SH, Kalani MY, Lim M, Ailles L, Huhn SL, Weissman IL. A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells. Neurosurgery 2009; 65: 237-250.
25. Alphonso A, Alahari SK. Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia 2009; 11: 1264-1271.
26. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism or pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 2000; 97: 12846-12851.
27. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-197.
28. Hall K, Ran S. Regulation of tumor angiogenesis by the local environment. Front Biosci 2010; 15: 195-212.
29. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
30. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71.
31. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
32. Lin ZX, Zhang PF, Jiang CZ, Chen ZB, He LZ, Chen JF. The exploration of relationship between immunohistochemistry of LN, FN, P53 and tumorous invasion microecosystem in human brain glioma. Acta Anatomica Sinica 2002; 33: 360-365.
33. Lin ZX, Yang LJ, Huang Q, Fu J. Activated vascular endothelia regulate invasion of glioma cells through expression of fibronectin. Chin Med J 2010; 123: 1754-1761.
34. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel cooption regression and growth in tumors mediated by angiopoietin and VEGF. Science 1999; 284: 1994-1998.
35. Rafii S. Circulating endothelial precursors: mystery, reality and promise. J Clin Invest 2000; 105: 17-19.
36. Alessandri G, Chirivi RG, Fiorentini S, Dossi R, Bonardelli S, Giulini SM, et al. Phenotypic and functional characteristics of tumor-derived microvascular endothelial cells. Clin Exp Metastasis 1999; 17: 655-662.
37. Roberts WG, Delaat J, Nagane M, Huang S, Cavenee WK, Palade GE. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 1998; 153: 1239-1248.
38. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessls: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998; 95: 4607-4612.
39. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the hematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841.
40. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007; 7: 733-736.
41. Louissaint A Jr, Rao S, Leventhal C, Goldman SA. Coordinated interaction of neurogenesis and angiogcnesis in the adult songbird brain. Neuron 2002; 34: 945-960.
42. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004; 304: 1338-1340.
43. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004; 116: 769-778.
44. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006; 66: 4553-4557.
45. Veeravagu A, Bababeygy SR, Kalani MY, Hou LC, Tse V. The cancer stem cell-vascular niche complex in brain tumor formation. Stem Cells Dev 2008; 17: 859-867.
46. Nie D. Cancer stem cell and niche. Front Biosci (Schol Ed) 2010; 2: 184-193.
47. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14: 123-129.
48. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.
49. Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 2007; 67: 3560-3564.
50. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-331.
51. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20: 781-810.
52. Kléber M, Sommer L. Wnt signaling and the regulation of stem cell funtion. Curr Opin Cell Biol 2004; 16: 681-687.
53. Kopper L, Hajdu M. Tumor stem cells. Pathol Oncol Res 2004; 10: 69-73.
54. Calabrese P, Tavaré S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol 2004; 164: 1337-1346.
55. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-1571.
56. Holland EC. Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2001; 2: 120-129.
57. Schiffer D, Manazza A, Tamagno I. Nestin expression in neuroepithelial tumors. Neurosci Lett 2006; 400: 80-85.
58. Tamagno I, Schiffer D. Nestin expression in reactive astrocytes of human pathology. J Neurooncol 2006; 80: 227-233.
59. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, Li H, et al. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 2006; 448: 485-492.
60. Parchment RE. Cancer treatment. In: Mckinnell RG, Parchment RE, Perantoni AO, et al, eds. The biological basis of cancer. Cambridge: Cambridge University Press; 1998: 218-249.
61. Fisher B, Saffer E, Rudock C, Coyle J, Gunduz N. Effect of local or systemmic treatment prior to primary tumor removal on the production and response to a serum growth stimulating factor in mice. Cancer Res 1989; 49: 2002-2004.
62. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
63. Pierce GB, Speers WC. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differntiation. Cancer Res 1988; 48: 1996-2004.
64. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004; 51: 1-28.
65. Kruizinga RC, Bestebroer J, Berghuis P, de Haas CJ, Links TP, De Vries EG, et al. Role of chemokines and their receptors in cancer. Curr Pharm Des 2009; 15: 3396-3416.
66. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-252.
67. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009; 1796: 293-308.
68. Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K. The role of angiogenesis in solid tumors: an overview. Eur J Intern Med 2009; 20: 666-671.
69. Azam F, Mehta S, Harris AL. Mechanisms of resistance to antiangiogenesis therapy. Eur J Cancer 2010; 46: 1323-1332.
70. Verhoeff JJ, van Tellingen O, Claes A, Staipers LJ, van Linde ME, Richei DJ, et al. Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme. BMC Cancer 2009; 9: 444-453.
71. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, et al. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2000; 2: 306-314.
72. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, et al. Hypoxia respose element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000; 95: 189-197.
73. Xu L, Fukumura D, Jain RK. Acidic extracellular PH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2MAPK signaling pathway: mechanism of low PH-induced VEGF. J Biol Chem 2002; 277: 11368-11374.
74. Pennachietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogenes. Cancer Cell 2003; 3: 347-361.
75. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, et al. Overexpression of hypoxia-inducible factor 1 is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002; 8: 1831-1837.
76. Hill RP, Marie-Egyptienne DT, Hedley DW. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009; 19: 106-111.
77. Sullivan R, Graham CH. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 2007; 26: 319-331.
78. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
79. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the pre-metastasic niche: within bone and beyond. Cancer Metastasis Rev 2006; 25: 521-529.
80. Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, et al. The antimumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J 2002; 16: 1802-1804.
81. Ramchandran R, Dhanabal M, Volk R, Waterman MJ, Segal M, Lu H, et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 1999; 255: 735-739.